CYTOMETRY PART B-CLINICAL CYTOMETRY

metrics 2024

Fostering interdisciplinary collaborations in clinical cytometry.

Introduction

CYTOMETRY PART B-CLINICAL CYTOMETRY, published by Wiley, is a premier journal dedicated to advancing the field of cytometry with a specific focus on its clinical applications. With an impact factor reflective of its influential role in the scientific community, this journal serves as an essential resource for researchers, professionals, and students keen on exploring the latest developments in pathology, histology, and cell biology. The journal holds impressive rankings—Q1 in Pathology and Forensic Medicine and Q2 in Histology—illustrating its critical standing within the academic landscape. Covering a wide array of topics from clinical techniques to innovative applications in cytometry, it aims to disseminate high-quality research findings that contribute to enhanced diagnostic and therapeutic strategies. As an Open Access journal, it ensures that its valuable content reaches a broader audience, facilitating knowledge-sharing and fostering collaborations across interdisciplinary fields. Since its inception in 2002, CYTOMETRY PART B continues to shape the future of clinical cytometry, making significant contributions to both academia and clinical practice.

Metrics 2024

SCIMAGO Journal Rank0.90
Journal Impact Factor2.30
Journal Impact Factor (5 years)2.50
H-Index69
Journal IF Without Self2.30
Eigen Factor0.00
Normal Eigen Factor0.39
Influence0.68
Immediacy Index1.10
Cited Half Life6.80
Citing Half Life7.00
JCI1.04
Total Documents1321
WOS Total Citations1740
SCIMAGO Total Citations8498
SCIMAGO SELF Citations1211
Scopus Journal Rank0.90
Cites / Document (2 Years)1.83
Cites / Document (3 Years)2.21
Cites / Document (4 Years)2.31

Metrics History

Rank 2024

Scopus

Pathology and Forensic Medicine in Medicine
Rank #34/208
Percentile 83.65
Quartile Q1
Histology in Medicine
Rank #14/62
Percentile 77.42
Quartile Q1
Cell Biology in Biochemistry, Genetics and Molecular Biology
Rank #132/285
Percentile 53.68
Quartile Q2

IF (Web Of Science)

MEDICAL LABORATORY TECHNOLOGY
Rank 16/30
Percentile 48.30
Quartile Q3
PATHOLOGY
Rank 42/88
Percentile 52.80
Quartile Q2

JCI (Web Of Science)

MEDICAL LABORATORY TECHNOLOGY
Rank 10/30
Percentile 66.67
Quartile Q2
PATHOLOGY
Rank 25/88
Percentile 71.59
Quartile Q2

Quartile History

Similar Journals

Clinical Pathology

Driving Excellence in Clinical Pathology Scholarship
Publisher: SAGE PUBLICATIONS LTDISSN: 2632-010XFrequency: 1 issue/year

Clinical Pathology, an esteemed journal published by SAGE Publications Ltd, stands at the forefront of advancing knowledge in the intersection of histology, microbiology, and pathology. As an Open Access journal since 2019, it provides researchers and healthcare professionals seamless access to high-quality, peer-reviewed articles that contribute to the field's growing body of knowledge. With a focus on enhancing diagnostic methodologies and advancing clinical applications, Clinical Pathology serves a diverse audience eager to explore innovative research and practical insights. The journal currently holds Q3 status in Histology and Pathology and Forensic Medicine, and Q4 in Medical Microbiology, reflecting its commitment to rigorous scholarship within a competitive landscape. Its ranking in Scopus further positions it as a vital resource for professionals striving for excellence in clinical and experimental pathology. We invite researchers, students, and professionals to engage with the latest findings and share their valuable contributions to help propel the field forward.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Connecting researchers with vital scientific knowledge.
Publisher: TAYLOR & FRANCIS LTDISSN: 0036-5513Frequency: 8 issues/year

The Scandinavian Journal of Clinical & Laboratory Investigation is a premier publication in the fields of clinical biochemistry and laboratory medicine, published by Taylor & Francis Ltd in the United Kingdom. With an ISSN of 0036-5513 and E-ISSN 1502-7686, this journal has been a vital source of scholarly articles since its inception in 1949, and is set to celebrate over seventy-five years of contributing to scientific knowledge in 2024. Ranked in the Q2 category for both Clinical Biochemistry and Medicine (Miscellaneous), it holds a robust position within the Scopus rankings, with a commendable rank of 77/117 in its discipline. The journal is dedicated to advancing research by offering a platform for high-quality studies that explore the development and application of clinical and laboratory investigations, making it essential reading for researchers, practitioners, and students interested in the latest advances and methodologies in the field. Although it does not currently offer Open Access, a wealth of valuable research insights awaits readers within its pages, highlighting its crucial role in fostering communication and innovation in clinical sciences.

Clinical Proteomics

Bridging the Gap Between Proteomics and Patient Care
Publisher: BMCISSN: 1542-6416Frequency: 1 issue/year

Clinical Proteomics is a leading open-access journal, published by BMC since 2011, that aims to advance the field of proteomics by providing a platform for the dissemination of original research, critical reviews, and technological advancements in the analysis of proteins and their roles in health and disease. With an ISSN of 1542-6416 and E-ISSN 1559-0275, this esteemed journal covers a broad scope, converging years of research from 2004 to 2024. As a distinguished publication, it holds a Q1 ranking in Clinical Biochemistry and Q2 in both Molecular Biology and Molecular Medicine, reflecting its significance in the scientific community. Clinical Proteomics' commitment to open access ensures that its content is readily available to researchers, professionals, and students worldwide, facilitating the exchange of knowledge and fostering collaborative efforts in proteomic studies. Situated in the United Kingdom, this journal plays a pivotal role in shaping the future of biomedical research, appealing to anyone keen on the integration of proteomics in clinical practice and molecular investigation.

JOURNAL OF IMMUNOLOGICAL METHODS

Transforming Immunology with Methodological Excellence
Publisher: ELSEVIERISSN: 0022-1759Frequency: 12 issues/year

JOURNAL OF IMMUNOLOGICAL METHODS, published by Elsevier, is a prominent academic journal dedicated to advancing the field of immunology through innovative methodological research. With an ISSN of 0022-1759 and E-ISSN 1872-7905, this quarterly journal has maintained a steady publication rhythm since its inception in 1971 and looks forward to continued contributions until 2024. Positioned in the Q3 quartile for both Immunology and Allergy as well as Immunology, the journal ranks #150 out of 233 in Immunology and Allergy and #164 out of 236 in Immunology and Microbiology according to Scopus metrics, indicating active engagement within its field despite its developing status. The journal aims to provide a comprehensive platform for researchers and professionals to disseminate high-quality findings, collaborate on foundational methods, and tackle the pressing challenges within immunological research, fostering a deeper understanding of immune responses and promoting advancements in allergy treatments. While it operates under a subscription model, the scholarly contributions offered within these pages are invaluable for those aiming to stay at the forefront of immunological methodologies.

Revista Romana de Medicina de Laborator

Unveiling the Future of Laboratory Medicine
Publisher: SCIENDOISSN: 1841-6624Frequency: 4 issues/year

Revista Romana de Medicina de Laborator is a prominent open-access journal published by SCIENDO, dedicated to the field of medical laboratory technology and biochemistry. Since its inception, this journal has been a vital platform for disseminating research findings and advancements in laboratory medicine. With an ISSN of 1841-6624 and E-ISSN 2284-5623, it has served the academic community since 2008 and has embraced an open-access model since 2013, ensuring that valuable research is accessible to all. While it features niche rankings in Scopus for areas such as Medical Laboratory Technology and Clinical Biochemistry, it consistently strives to engage researchers, professionals, and students. Its rich collection of articles highlights innovative techniques and methodologies, supporting the ongoing development of laboratory practices. Although its coverage in Scopus has been discontinued, the journal continues to publish high-quality studies that contribute significantly to the field, fostering knowledge exchange essential for advancing medical science.

Practical Laboratory Medicine

Exploring Breakthroughs in Biochemistry and Radiology
Publisher: ELSEVIERISSN: Frequency: 3 issues/year

Practical Laboratory Medicine is a distinguished peer-reviewed journal published by Elsevier, focusing on the essential advances in the fields of clinical biochemistry and radiological technology. Begun in 2015, this Open Access journal fosters an environment of scholarly communication, ensuring that valuable research is freely available to a global audience. With a current impact factor placing it in the Q3 quartile in both clinical biochemistry and radiological and ultrasound technology, the journal serves as a vital platform for researchers and professionals to disseminate innovative findings and foster interdisciplinary collaboration. The journal’s commitment to covering a broad spectrum of laboratory medicine topics, from clinical practice improvements to technological developments, underlines its importance in enhancing laboratory standards and patient care. Based in Amsterdam, Netherlands, Practical Laboratory Medicine not only contributes to the academic community but also influences practical applications in healthcare settings.

Journal of Cytology

Elevating Standards in Cytology: Bridging Research and Practice.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-9371Frequency: 4 issues/year

Journal of Cytology, published by Wolters Kluwer Medknow Publications, stands as a pivotal resource in the fields of cytology, histology, and pathology. With an ISSN of 0970-9371 and an E-ISSN of 0974-5165, this peer-reviewed, open-access journal has been disseminating vital research since its inception in 1985, transitioning to open access in 2008 to enhance global accessibility to its scholarly articles. Operating from its base in Mumbai, India, the journal is categorized in the Q3 quartile for histology and pathology according to the 2023 rankings, affirming its ongoing contribution to the scientific community. Researchers and professionals can benefit from a wide array of cutting-edge studies and reviews that advance the understanding of cytological practices. The journal's commitment to disseminating high-impact research is reflected in its Scopus rankings, positioning it among the significant players in its field. By facilitating open access, the Journal of Cytology aims to foster knowledge exchange and inspire new investigations among scholars, clinicians, and students alike.

CLINICAL NUCLEAR MEDICINE

Bridging Research and Clinical Applications in Nuclear Medicine
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0363-9762Frequency: 12 issues/year

CLINICAL NUCLEAR MEDICINE is a premier journal dedicated to the field of nuclear medicine, published by Lippincott Williams & Wilkins. With a history of excellence since its inception in 1978, the journal serves as a vital resource for researchers, healthcare professionals, and students seeking to deepen their understanding of this rapidly evolving discipline. The journal holds a commendable Q2 ranking in both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging, reflecting its significant impact on advancing clinical practices and research. While currently not offered as an open-access publication, CLINICAL NUCLEAR MEDICINE ensures rigorous peer review and high-quality publications, contributing to the broad dissemination of cutting-edge studies and reviews. With its comprehensive scope encompassing both diagnostic and therapeutic nuclear medicine applications, researchers around the globe turn to this journal to stay informed and inspire innovations in patient care for the years leading up to 2024 and beyond.

DIAGNOSTIC CYTOPATHOLOGY

Advancing the Art of Diagnosis through Cytopathology
Publisher: WILEYISSN: 8755-1039Frequency: 12 issues/year

DIAGNOSTIC CYTOPATHOLOGY is a scholarly journal dedicated to advancing the field of cytopathology through the publication of high-quality research and reviews. Founded in 1985 and published by Wiley, this journal provides vital insights into the diagnosis and management of diseases through cytological techniques. With a strong presence in the academic community, it currently holds a Q3 ranking in the fields of Histology, Medicine (miscellaneous), and Pathology and Forensic Medicine, reflecting its commitment to fostering knowledge and innovation in these areas. Researchers and clinicians alike can benefit from its comprehensive articles that delve into cutting-edge methodologies and diagnostic strategies. Although not an Open Access journal, DIAGNOSTIC CYTOPATHOLOGY remains a crucial resource for professionals seeking to enhance their understanding and practice in the diagnostic realm. With an ISSN of 8755-1039 and an E-ISSN of 1097-0339, the journal continues to publish impactful studies well into 2024, ensuring that essential advancements in cytopathology reach a global audience.

Radiology-Cardiothoracic Imaging

Innovative Insights for Radiological Excellence
Publisher: RADIOLOGICAL SOC NORTH AMERICA (RSNA)ISSN: 2638-6135Frequency: 6 issues/year

Radiology-Cardiothoracic Imaging, published by the Radiological Society of North America (RSNA), is a leading peer-reviewed journal dedicated to advancing knowledge in the field of cardiothoracic radiology. With an ISSN of 2638-6135 and a remarkable 2023 Scopus ranking of #5 out of 333 in its category, the journal stands out in the Q1 tier for Radiology, Nuclear Medicine, and Imaging, showcasing its significant impact and high-quality research contributions. The journal is committed to providing an open platform for innovative research, insightful reviews, and clinical studies that address the complexities of cardiothoracic imaging, thereby facilitating the enhancement of diagnostic and therapeutic strategies. Operating out of Oak Brook, Illinois, the journal aims to engage a diverse audience of researchers, professionals, and students, fostering collaboration and knowledge exchange within this vital area of radiological science. With a convergence of years extending from 2019 to 2024, Radiology-Cardiothoracic Imaging remains at the forefront of emerging trends and findings, making it an essential resource for anyone passionate about the evolving landscape of cardiothoracic imaging.